Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.

Coignard-Biehler H, Mahlaoui N, Pilmis B, Barlogis V, Brosselin P, De Vergnes N, Debré M, Malphettes M, Frange P, Catherinot E, Pellier I, Durieu I, Perlat A, Royer B, Le Quellec A, Jeziorski E, Fischer A, Lortholary O; CEREDIH French PID study group, Aaron L, Adoue D, Aguilar C, Aladjidi N, Alcais A, Amoura Z, Arlet P, Armari-Alla C, Bader-Meunier B, Bayart S, Bertrand Y, Bienvenu B, Blanche S, Bodet D, Bonnotte B, Borie R, Boutard P, Briandet C, Brion JP, Brouard J, Cohen-Beaussant S, Costes L, Couderc LJ, Cougoul P, Courteille V, de Saint Basile G, Devoldere C, Deville A, Donadieu J, Dore E, Dulieu F, Edan C, Entz-Werle N, Fieschi C, Forestier A, Fouyssac F, Gajdos V, Galicier L, Gandemer V, Gardembas M, Gaud C, Guillerm G, Hachulla E, Hamidou M, Hermine O, Hoarau C, Humbert S, Jaccard A, Jacquot S, Jais JP, Jaussaud R, Jeandel PY, Kebaili K, Korganow AS, Lambotte O, Lanternier F, Larroche C, Lascaux AS, Le Moigne E, Le Moing V, Lebranchu Y, Lecuit M, Lefevre G, Lemal R, Te VLT, Marie-Cardine A, Silva NM, Masseau A, Massot C, Mazingue F, Merlin E, Michel G, Millot F, Monlibert B, Monpoux F, Moshous D, Mouthon L, Munzer M, Neven B, Nove-Josserand R, Oksenhendler E, Ouachée-Chardin M, Oudot C, Pagnier A, Pasquali JL, Pasquet M, Perel Y, Picard C, Piguet C, Plantaz D, Provot J, Quartier P, Rieux-Laucat F, Roblot P, Roger PM, Rohrlich PS, Rubie H, Salle V, Sarrot-Reynauld F, Servettaz A, Stephan JL, Schleinitz N, Suarez F, Swiader L, Taque S, Thomas C, Tournilhac O, Thumerelle C, Tron F, Vannier JP, Viallard JF.

J Clin Immunol. 2019 Oct;39(7):702-712. doi: 10.1007/s10875-019-00658-9. Epub 2019 Aug 10.

PMID:
31401750
2.

Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort.

Fouquet C, Le Rouzic MA, Leblanc T, Fouyssac F, Leverger G, Hessissen L, Marlin S, Bourrat E, Fahd M, Raffoux E, Vannier JP, Jäkel N, Knoefler R, Triolo V, Pasquet M, Bayart S, Thuret I, Lutz P, Vermylen C, Touati M, Rose C, Matthes T, Isidor B, Kannengiesser C, Ducassou S.

Br J Haematol. 2019 Nov;187(4):530-542. doi: 10.1111/bjh.16100. Epub 2019 Jul 23.

PMID:
31338833
3.

Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France.

Bernaudin F, Dalle JH, Bories D, Peffault de Latour R, Robin M, Bertrand Y, Pondarre C, Vannier JP, Neven B, Kuentz M, Maury S, Lutz P, Paillard C, Yakouben K, Thuret I, Galambrun C, Dhedin N, Jubert C, Rohrlich P, Bay JO, Suarez F, Raus N, Vernant JP, Gluckman E, Poirot C, Socié G; Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Haematologica. 2019 May 16. pii: haematol.2018.213207. doi: 10.3324/haematol.2018.213207. [Epub ahead of print]

4.

Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease.

Cappelli B, Volt F, Tozatto-Maio K, Scigliuolo GM, Ferster A, Dupont S, Simões BP, Al-Seraihy A, Aljurf MD, Almohareb F, Belendez C, Matthes S, Dhedin N, Pondarre C, Dalle JH, Bertrand Y, Vannier JP, Kuentz M, Lutz P, Michel G, Rafii H, Neven B, Zecca M, Bader P, Cavazzana M, Labopin M, Locatelli F, Magnani A, Ruggeri A, Rocha V, Bernaudin F, de La Fuente J, Corbacioglu S, Gluckman E; Eurocord, the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Paediatric Diseases Working Party (PDWP) of the EBMT.

Haematologica. 2019 Dec;104(12):e543-e546. doi: 10.3324/haematol.2019.216788. Epub 2019 Apr 24. No abstract available.

5.

Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin.

Abdoul-Azize S, Buquet C, Li H, Picquenot JM, Vannier JP.

Oncogene. 2018 Sep;37(36):4979-4993. doi: 10.1038/s41388-018-0329-6. Epub 2018 May 23.

PMID:
29795329
6.

Synergistic promoting effects of pentoxifylline and simvastatin on the apoptosis of triple-negative MDA-MB-231 breast cancer cells.

Castellanos-Esparza YC, Wu S, Huang L, Buquet C, Shen R, Sanchez-Gonzalez B, García Latorre EA, Boyer O, Varin R, Jiménez-Zamudio LA, Janin A, Vannier JP, Li H, Lu H.

Int J Oncol. 2018 Apr;52(4):1246-1254. doi: 10.3892/ijo.2018.4272. Epub 2018 Feb 9.

PMID:
29436616
7.

Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).

Chevret S, Verlhac S, Ducros-Miralles E, Dalle JH, de Latour RP, de Montalembert M, Benkerrou M, Pondarré C, Thuret I, Guitton C, Lesprit E, Etienne-Julan M, Elana G, Vannier JP, Lutz P, Neven B, Galambrun C, Paillard C, Runel C, Jubert C, Arnaud C, Kamdem A, Brousse V, Missud F, Petras M, Doumdo-Divialle L, Berger C, Fréard F, Taieb O, Drain E, Elmaleh M, Vasile M, Khelif Y, Bernaudin M, Chadebech P, Pirenne F, Socié G, Bernaudin F.

Contemp Clin Trials. 2017 Nov;62:91-104. doi: 10.1016/j.cct.2017.08.008. Epub 2017 Aug 15.

PMID:
28821470
8.

Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation.

Le Rouzic MA, Fouquet C, Leblanc T, Touati M, Fouyssac F, Vermylen C, Jäkel N, Guichard JF, Maloum K, Toutain F, Lutz P, Perel Y, Manceau H, Kannengiesser C, Vannier JP.

Blood Cells Mol Dis. 2017 Jul;66:11-18. doi: 10.1016/j.bcmd.2017.07.003. Epub 2017 Jul 26.

PMID:
28772256
9.
10.

A biomimetic hydrogel functionalized with adipose ECM components as a microenvironment for the 3D culture of human and murine adipocytes.

Louis F, Pannetier P, Souguir Z, Le Cerf D, Valet P, Vannier JP, Vidal G, Demange E.

Biotechnol Bioeng. 2017 Aug;114(8):1813-1824. doi: 10.1002/bit.26306. Epub 2017 May 8.

PMID:
28398656
11.

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.

de Montalembert M, Ribeil JA, Brousse V, Guerci-Bresler A, Stamatoullas A, Vannier JP, Dumesnil C, Lahary A, Touati M, Bouabdallah K, Cavazzana M, Chauzit E, Baptiste A, Lefebvre T, Puy H, Elie C, Karim Z, Ernst O, Rose C.

PLoS One. 2017 Mar 3;12(3):e0172147. doi: 10.1371/journal.pone.0172147. eCollection 2017.

12.

[Modulation of glucocorticoid sensitivity in acute lymphoblastic leukemia: Pyr3, a new therapeutic tool?]

Abdoul-Azize S, Dubus I, Vannier JP.

Med Sci (Paris). 2017 Feb;33(2):130-132. doi: 10.1051/medsci/20173302005. Epub 2017 Feb 27. French. No abstract available.

13.

Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).

Roux C, Tifratene K, Socié G, Galambrun C, Bertrand Y, Rialland F, Jubert C, Pochon C, Paillard C, Sirvent A, Nelken B, Vannier JP, Freycon C, Beguin Y, Raus N, Yakoub-Agha I, Mohty M, Dalle JH, Michel G, Pradier C, Peffault de Latour R, Rohrlich PS.

Bone Marrow Transplant. 2017 May;52(5):678-682. doi: 10.1038/bmt.2016.360. Epub 2017 Jan 23.

14.

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.

Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Pinto Simões B, Ferster A, Dupont S, de la Fuente J, Dalle JH, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand Y, Vannier JP, Ayas M, Cavazzana M, Matthes-Martin S, Rocha V, Elayoubi H, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M; Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research.

Blood. 2017 Mar 16;129(11):1548-1556. doi: 10.1182/blood-2016-10-745711. Epub 2016 Dec 13.

15.

Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience.

Alloin AL, Leverger G, Dalle JH, Galambrun C, Bertrand Y, Baruchel A, Auvrignon A, Gandemer V, Ragu C, Loundou A, Bilhou-Nabera C, Lafage-Pochitaloff M, Dastugue N, Nelken B, Jubert C, Rialland F, Plat G, Pochon C, Vannier JP, Rohrlich PS, Kanold J, Lutz P, Sirvent A, Oudin C, Cuccuini W, Michel G.

Bone Marrow Transplant. 2017 Apr;52(4):516-521. doi: 10.1038/bmt.2016.293. Epub 2016 Dec 12.

PMID:
27941778
16.

Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways.

Petit C, Gouel F, Dubus I, Heuclin C, Roget K, Vannier JP.

BMC Cancer. 2016 Sep 22;16(1):746. doi: 10.1186/s12885-016-2776-1.

17.
18.

Synergistic influence of topomimetic and chondroitin sulfate-based treatments on osteogenic potential of Ti-6Al-4V.

Labat B, Morin-Grognet S, Gaudière F, Bertolini-Forno L, Thoumire O, Vannier JP, Ladam G, Atmani H.

J Biomed Mater Res A. 2016 Aug;104(8):1988-2000. doi: 10.1002/jbm.a.35732. Epub 2016 Apr 18.

PMID:
27038078
19.

A New Intergenic α-Globin Deletion (α-αΔ125) Found in a Kabyle Population.

Singh AR, Lacan P, Cadet E, Bignet P, Dumesnil C, Vannier JP, Joly P, Rochette J.

Hemoglobin. 2016;40(2):108-12. doi: 10.3109/03630269.2015.1136640.

PMID:
26911300
20.

Ifosfamide-induced encephalopathy due to a novel formulation of ifosfamide.

Filhon B, Lacarra B, Hervouet C, Jaffray M, Schneider P, Vannier JP.

Pediatr Blood Cancer. 2016 Feb;63(2):372-3. doi: 10.1002/pbc.25724. Epub 2015 Sep 23. No abstract available.

PMID:
26397980
21.

Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia.

Ruminy P, Marchand V, Buchbinder N, Larson T, Joly B, Penther D, Lemasle E, Lepretre S, Angot E, Mareschal S, Viailly PJ, Dubois S, Clatot F, Viennot M, Bohers E, Rizzo D, Cornic M, Bertrand P, Girod C, Camus V, Etancelin P, Buchonnet G, Schneider P, Picquenot JM, Vannier JP, Bastard C, Tilly H, Jardin F.

Leukemia. 2016 Mar;30(3):757-60. doi: 10.1038/leu.2015.177. Epub 2015 Jul 3. No abstract available.

PMID:
26139430
22.

Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2.

Hochart A, Gaillard V, Baroncini M, André N, Vannier JP, Vinchon M, Dubrulle F, Lejeune JP, Vincent C, Nève V, Sudour Bonnange H, Bonne NX, Leblond P.

J Neurooncol. 2015 Sep;124(2):229-36. doi: 10.1007/s11060-015-1828-8. Epub 2015 May 29.

PMID:
26022982
23.

Salvage therapy with gemcitabine, vinorelbine, and pegylated liposomal doxorubicin for relapsed or refractory pediatric Hodgkin lymphoma. Results of a retrospective series of four children.

Jaffray M, Buchbinder N, Lutun A, Schneider P, Piquenot JM, Vannier JP.

Ann Hematol. 2015 Aug;94(8):1401-6. doi: 10.1007/s00277-015-2362-7. Epub 2015 Apr 12.

PMID:
25862234
24.

[Tetraspanins: a new target for antiangiogenic therapy?].

Vasse M, Colin S, Guilmain W, Creoff E, Muraine M, Vannier JP, Al-Mahmood S.

Ann Pharm Fr. 2015 Mar;73(2):100-7. doi: 10.1016/j.pharma.2014.07.002. Epub 2014 Sep 4. Review. French.

PMID:
25745942
25.

Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.

Huang L, Hu C, DI Benedetto M, Varin R, Liu J, Jin J, Wang L, Vannier JP, Janin A, Lu H, Li H.

Oncol Lett. 2015 Mar;9(3):1287-1292. Epub 2014 Dec 22.

26.

Comparative study of the effect of rivaroxaban and fondaparinux on monocyte's coagulant activity and cytokine release.

Laurent M, Joimel U, Varin R, Cazin L, Gest C, Le-Cam-Duchez V, Jin J, Liu J, Vannier JP, Lu H, Soria J, Li H, Soria C.

Exp Hematol Oncol. 2014 Dec 17;3(1):30. doi: 10.1186/2162-3619-3-30. eCollection 2014.

27.

Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib.

Huang L, Hu C, Di Benedetto M, Varin R, Liu J, Wang L, Vannier JP, Jin J, Janin A, Lu H, Li H.

Onco Targets Ther. 2014 Dec 4;7:2249-55. doi: 10.2147/OTT.S67251. eCollection 2014.

28.

[Delayed haemolytic transfusion reaction: About 3 patients with sickle cell disease].

Bertrand E, Dumesnil C, Lahary A, Al Bagami M, Schneider P, Lévesque H, Vannier JP.

Rev Med Interne. 2015 Nov;36(11):769-72. doi: 10.1016/j.revmed.2014.11.015. Epub 2014 Dec 17. French.

PMID:
25529378
29.

Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French Severe Congenital Neutropenia Registry.

Desplantes C, Fremond ML, Beaupain B, Harousseau JL, Buzyn A, Pellier I, Roques G, Morville P, Paillard C, Bruneau J, Pinson L, Jeziorski E, Vannier JP, Picard C, Bellanger F, Romero N, de Pontual L, Lapillonne H, Lutz P, Chantelot CB, Donadieu J.

Orphanet J Rare Dis. 2014 Dec 10;9:183. doi: 10.1186/s13023-014-0183-8.

30.

[Cerebral venous thrombosis and immune thrombocytopenia in a 7-year-old girl: a fortuitous association?].

Cotillon M, Lebas A, Blanc T, Schneider P, Vannier JP, Buchbinder N.

Arch Pediatr. 2014 Dec;21(12):1367-9. doi: 10.1016/j.arcped.2014.09.014. Epub 2014 Nov 6. French.

PMID:
25445130
31.

Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia.

Filhon B, Dumesnil C, Van Dreden P, Schneider P, Vasse M, Vannier JP.

Thromb Res. 2014 Nov;134(5):1164-6. doi: 10.1016/j.thromres.2014.08.015. Epub 2014 Aug 29. No abstract available.

PMID:
25204998
32.

Detection of dicentric chromosome (9;20) in paediatric B-cell acute lymphoblastic leukaemia: prognostic significance.

Letouzey M, Penther D, Roche-Lestienne C, Nelken B, Devoldère C, Vannier JP, Schneider P.

Ann Hematol. 2015 Feb;94(2):187-93. doi: 10.1007/s00277-014-2204-z. Epub 2014 Sep 6.

PMID:
25193356
33.

Proteomic profile of pre - B2 lymphoblasts from children with acute lymphoblastic leukemia (ALL) in relation with the translocation (12; 21).

Costa O, Schneider P, Coquet L, Chan P, Penther D, Legrand E, Jouenne T, Vasse M, Vannier JP.

Clin Proteomics. 2014 Aug 1;11(1):31. doi: 10.1186/1559-0275-11-31. eCollection 2014.

34.

Direct effect of bevacizumab on glioblastoma cell lines in vitro.

Simon T, Coquerel B, Petit A, Kassim Y, Demange E, Le Cerf D, Perrot V, Vannier JP.

Neuromolecular Med. 2014 Dec;16(4):752-71. doi: 10.1007/s12017-014-8324-8. Epub 2014 Aug 13.

PMID:
25113866
35.

Genipin-cross-linked layer-by-layer assemblies: biocompatible microenvironments to direct bone cell fate.

Gaudière F, Morin-Grognet S, Bidault L, Lembré P, Pauthe E, Vannier JP, Atmani H, Ladam G, Labat B.

Biomacromolecules. 2014 May 12;15(5):1602-11. doi: 10.1021/bm401866w. Epub 2014 Apr 8.

PMID:
24666097
36.

Precocious initiation of spermatogenesis in a 19-month-old boy with Hurler syndrome.

Milazzo JP, Bironneau A, Vannier JP, Liard-Zmuda A, Macé B, Nathalie R.

Basic Clin Androl. 2014 May 1;24:8. doi: 10.1186/2051-4190-24-8. eCollection 2014.

37.

The small GTPase RhoA regulates the expression and function of the sodium channel Nav1.5 in breast cancer cells.

Dulong C, Fang YJ, Gest C, Zhou MH, Patte-Mensah C, Mensah-Nyagan AG, Vannier JP, Lu H, Soria C, Cazin L, Mei YA, Varin R, Li H.

Int J Oncol. 2014 Feb;44(2):539-47. doi: 10.3892/ijo.2013.2214. Epub 2013 Dec 10.

PMID:
24337141
38.

Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

de Berranger E, Cousien A, Petit A, Peffault de Latour R, Galambrun C, Bertrand Y, Salmon A, Rialland F, Rohrlich PS, Vannier JP, Lutz P, Yakouben K, Duhamel A, Bruno B, Michel G, Dalle JH.

Bone Marrow Transplant. 2014 Mar;49(3):382-8. doi: 10.1038/bmt.2013.185. Epub 2013 Dec 9.

PMID:
24317131
39.

Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells.

Petit A, Delaune A, Falluel-Morel A, Goullé JP, Vannier JP, Dubus I, Vasse M.

Pharmacol Res. 2013 Nov;77:11-21. doi: 10.1016/j.phrs.2013.08.005. Epub 2013 Sep 1.

PMID:
24004656
40.

Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Paillard C, Rochette E, Lutz P, Bertrand Y, Michel G, Bordigoni P, Dalle JH, Rohrlich P, Vannier JP, Perel Y, Plantaz D, Leverger G, Sirvent A, Dore E, Isfan F, Merlin E, Pereira B, Halle P, Rabiau N, Kanold J, Deméocq F.

Bone Marrow Transplant. 2013 Nov;48(11):1401-8. doi: 10.1038/bmt.2013.82. Epub 2013 Jun 10.

PMID:
23749103
41.

[Cryopreservation of testicular tissue in children].

Rives N, Milazzo JP, Travers A, Arkoun B, Bironneau A, Sibert L, Liard-Zmuda A, Marie-Cardine A, Schneider P, Vannier JP, Macé B.

Bull Acad Natl Med. 2013 Apr-May;197(4-5):877-86; discussion 886. Review. French.

PMID:
25518156
42.

[Steroid intake before leukemia diagnosis impairs outcome in childhood acute lymphoblastic leukemia].

Gatineau-Sailliant S, Buchbinder N, Callat MP, Nelken B, Pautard B, Vannier JP, Schneider P.

Arch Pediatr. 2013 Apr;20(4):341-7. doi: 10.1016/j.arcped.2013.01.016. Epub 2013 Feb 21. French.

PMID:
23433842
43.

Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines.

Gest C, Joimel U, Huang L, Pritchard LL, Petit A, Dulong C, Buquet C, Hu CQ, Mirshahi P, Laurent M, Fauvel-Lafève F, Cazin L, Vannier JP, Lu H, Soria J, Li H, Varin R, Soria C.

BMC Cancer. 2013 Feb 6;13:63. doi: 10.1186/1471-2407-13-63.

44.

Importance of local hypoxia on endothelial phenotype for an in vitro approach to bone marrow angiogenesis.

Gouel F, Kamanzi S, Corbière C, Buquet C, Legrand E, Vannier JP, Mulder P, Vasse M, Dubus I.

Leuk Res. 2012 Sep;36(9):1200-3. doi: 10.1016/j.leukres.2012.05.026. Epub 2012 Jun 26.

PMID:
22742817
45.

Malignant transformations in a patient with a mediastinal germ cell tumour: lack of efficacy of bone marrow transplantation after chemotherapy on tumour recurrence.

Kassim Y, Penther D, Schneider P, Callat MP, Bastard C, Vannier JP.

BMJ Case Rep. 2012 Jun 14;2012. pii: bcr0820114663. doi: 10.1136/bcr.08.2011.4663.

46.

[Advantages and difficulties of an erythrocytapheresis program for sickle-cell patients: a pediatric experience].

Filhon B, Dumesnil C, Holtermann C, Bastit D, Schneider P, Vannier JP.

Arch Pediatr. 2012 Jun;19(6):572-8. doi: 10.1016/j.arcped.2012.03.014. Epub 2012 Apr 27. French.

PMID:
22542721
47.

Risk adapted chemotherapy for localised Ewing's sarcoma of bone: the French EW93 study.

Gaspar N, Rey A, Bérard PM, Michon J, Gentet JC, Tabone MD, Roché H, Defachelles AS, Lejars O, Plouvier E, Schmitt C, Bui B, Boutard P, Taque S, Munzer M, Vannier JP, Plantaz D, Entz-Werle N, Oberlin O.

Eur J Cancer. 2012 Jun;48(9):1376-85. doi: 10.1016/j.ejca.2012.03.017. Epub 2012 Apr 18. Erratum in: Eur J Cancer. 2013 Jun;49(9):2276. Enz-Werlé, Natacha [corrected to Entz-Werle, Natacha].

PMID:
22516209
48.

Survival of cord blood haematopoietic stem cells in a hyaluronan hydrogel for ex vivo biomimicry.

Demange E, Kassim Y, Petit C, Buquet C, Dulong V, Cerf DL, Buchonnet G, Vannier JP.

J Tissue Eng Regen Med. 2013 Nov;7(11):901-10. doi: 10.1002/term.1482. Epub 2012 Mar 31.

PMID:
22473677
49.

Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets.

Gest C, Mirshahi P, Li H, Pritchard LL, Joimel U, Blot E, Chidiac J, Poletto B, Vannier JP, Varin R, Mirshahi M, Cazin L, Pujade-Lauraine E, Soria J, Soria C.

Cancer Lett. 2012 Apr 28;317(2):207-17. doi: 10.1016/j.canlet.2011.11.026. Epub 2011 Nov 25.

PMID:
22120672
50.

What role for angiogenesis in childhood acute lymphoblastic leukaemia?

Schneider P, Dubus I, Gouel F, Legrand E, Vannier JP, Vasse M.

Adv Hematol. 2011;2011:274628. doi: 10.1155/2011/274628. Epub 2011 Nov 9.

Supplemental Content

Loading ...
Support Center